Treatment Of Diabetes Is Different For Men And Women

Treatment Of Diabetes Is Different For Men And Women.
Widely in use diabetes drugs have distinguishable things on men's and women's hearts, a brand-new study suggests. Researchers examined how three commonly prescribed treatments for exemplar 2 diabetes affected 78 patients who were divided into three groups. One faction took metformin alone, the sponsor group took metformin additional rosiglitazone (sold under the brand name Avandia) and the third crowd took metformin plus Lovaza, a type of fish oil sildenafil box. Metformin reduces blood sugar assembly by the liver and improves insulin sensitivity.

Rosiglitazone also improves insulin receptivity and moves unfastened fatty acids out of the blood. Lovaza lowers blood levels of another sort of fat called triglycerides. The researchers found that the drugs had very new and sometimes opposite effects on the hearts of men and women, even as the drugs controlled blood sugar equally well in both genders vigrx box. The cramming appears in the December outgoing of the American Journal of Physiology - Heart and Circulatory Physiology.

Although metformin had unqualified sincerity effects in women, it caused the magnanimity metabolism of men to burn less sugar and more fats. Chronic fervent of fat by the heart results in harmful changes that can create to heart failure, said the researchers, from the Washington University School of Medicine in St Louis. "Instead of making basics metabolism more common in men, metformin alone made it worse, looking even more peer a diabetic heart," study ranking author Dr Robert Gropler said in a university newsflash release.

And "But in women, metformin had the desired effect - lowering plumpness metabolism and increasing glucose perspicacity by the heart". Taking either rosiglitazone or Lovaza with metformin seemed to compress some of the negative heart effects of metformin alone in men. Taking rosiglitazone in ell to metformin further improved women's sensitivity metabolism, compared to taking metformin alone.

The addition of Lovaza to metformin did not have a heady effect either way for men or women, the researchers said. "Our scan suggests that we need to better define which therapies are optimal for women with diabetes and which ones are optimal for men," said Gropler, a professor of radiology. The cram did not, however, end up a cause-and-effect associate between the drug combinations and centre changes seeking. It showed only an association.